Some basic factors essential to autogeneic nonvascularized onlay bone grafting to the craniofacial skeleton

Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery

Volumn 33, Issue 2, 1999, Pages 129-146

  Gordh, Monica ^a   Alberius, Per ^b  

^a MALMÖ UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Animals; Bone; Bone grafts; Growth factor; Osteopromotive membranes

Indexed keywords

BONE DERIVED GROWTH FACTOR; BONE MORPHOGENETIC PROTEIN; GROWTH PROMOTOR;

ANIMAL MODEL; ARTICLE; BONE ALLOGRAFT; BONE DEVELOPMENT; BONE GRAFT; BONE MARROW TRANSPLANTATION; BONE REMODELING; CRANIOFACIAL SURGERY; EMBRYONAL TISSUE; GRAFT SURVIVAL; HUMAN; NONHUMAN; OSTEOSYNTHESIS; RECIPIENT; REVASCULARIZATION;

EID: 5844325732     PISSN: 02844311     EISSN: None     Source Type: Journal    
DOI: 10.1080/02844319950159370     Document Type: Article

References (134)

1. 1. Alberius P, Dahlin C, Linde A. Role of osteopromotion in experimental bone grafting to the skull: a study in adult rats using a membrane technique. J Oral Maxillofac Surg 1992; 50: 829-834.
2. 2. Alberius P, Gordh M. Failure of onlay bone grafts to integrate over the calvarial suture: observations in adult ìsogeneìc rats. J Craniomaxillofac Surg 1996; 24: 251-255.
3. 3. Alberius P, Gordh M. Osteopontin and bone sialoprotein distribution at the bone graft recipient site. Arch Otolaryngol Head Neck Surg 1998; 124: 1382-1386.
4. 4. Alberius P, Gordh M, Lindberg L, Johnell O. Influence of surrounding soft tissues on onlay bone graft incorporation. Oral Surg Oral Med Oral Pathol 1996; 82: 22-33.
5. 5. Alberius P, Gordh M, Lindberg L, Johnell O. Onlay bone graft behaviour after marrow exposure of the recipient rat skull bone. Scand J Plast Reconstr Surg Hand Surg 1996; 30: 257-266.
6. 6. Alberius P, Gordh M, Lindberg L, Johnell O. Effect of cortical perforations of both graft and host bed on onlay incorporation to the rat skull. Eur J Oral Sci 1996; 104: 554-561.
7. 7. Albrektsson T. Repair of bone grafts. A vital microscopic and histologic investigation in the rabbit. Scand J Plast Reconstr Surg 1980; 14: 1-12.
8. 8. Albrektsson T. In vivo studies of bone graft. The possibility of vascular anastomoses in healing bone. Acta Orthop Scand 1980; 51: 9-17.
9. 9. Aspenberg P, Wang E, Thorngren KG. Bone morphogenetic protein induces bone in the squirrel monkey, but bone matrix does not. Acta Orthop Scand 1992; 63: 619-622.
10. 10. Aspenberg P, Jeppsson C, Wang JS, Boström M. Transforming growth factor beta and bone morphogenetic protein 2 for bone ingrowth: a comparison using bone chambers in rats. Bone 1996; 19: 499-503.
11. 11. Bartlett SP, Lin KY, Yaremchuk MJ, Fallon M, Grossman RS, Whitaker LA. Membranous versus endochondral bone. Reply. (Correspondence). Plast Reconstr Surg 1991; 87: 1145.
12. 12. Bassett CAL, Clinical implication of cell function in bone grafting. Clin Orthop 1972; 87: 49-59.
13. 13. Beck LS, Amento EP, Xu Y, et al. TGF-β1 induces bone closure of skull defects: temporal dynamics of bone formation in defects exposed to rhTGF-β1. J Bone Miner Res 1993; 8: 753-761.
14. 14. Bostrom M, Lane JM, Tomin E, et al. Use of bone morphogenetic protein-2 in the rabbit ulnar nonunion model. Clin Orthop 1996; 327: 272-282.
15. 15. Brånemark P-I, Hansson BO, Adell R, et al. Osseointegrated implants in the treatment of the edentulous jaw. Scand J Plast Reconstr Surg 1977; 11: suppl 16.
16. 16. Burchardt H. The biology of bone graft repair. Clin Orthop 1983; 174: 28-42.
17. 17. Burchardt H, Busbee III GA, Enniking WF. Repair of experimental autologous grafts of cortical bone. J Bone Joint Surg 1975; 57A: 814-819.
18. 18. Burchardt H, Enneking WF. Transplantation of bone. Symposium on organ transplantation. Surg Clin North Am 1978; 58: 403-427.
19. 19. Burwell RG. Studies in the transplantation of bone. VIII. Treated composite homograft autografts of cancellous bone: an analysis of inductive mechanisms in bone transplantation. J Bone Joint Surg 1966; 48B: 532-566.
20. 20. Burwell RG. The fate of bone grafts. In: Apley AG, ed. Recent advances in orthopaedics. London: Churchill, 1969: 115-207.
21. 21. Burwell RG. The function of bone marrow in the incorporation of a bone graft. Clin Orthop 1985; 200: 125-141.
22. 22. Buser D, Ruskin J, Higginbottom F, Hardwick R, Dahlin C, Schenk R. Osseointegration of titanium implants in bone regenerated in membrane-protected defects: a histologic study in the canine mandible. Int J Oral Maxillofac Implants 1995; 10: 666-681.
23. 23. Celeste AJ, Jannazzi JA, Taylor RC, et al. Identification of transforming growth factor β family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci U S A 1990; 87: 9843-9847.
24. 24. Celeste AJ, Song JJ, Cox K, Rosen V, Wozney JM. Bone morphogenetic protein-9, a new member of the TGF-β super-family. J Bone Miner Res 1994; 9 (suppl): S136.
25. 25. Chen NT, Glowacki J, Bucky LP, Hong H-Z, Kim W-K, Yaremchuk MJ. The roles of revascularization and resorption on endurance of craniofacial onlay bone grafts in the rabbit. Plast Reconstr Surg 1994; 93: 714-722.
26. 26. Cook SD, Wolfe MW, Salkeld SL, Rueger DC. Effect of recombinant human osteogenic protein-1 on healing of segmental defects in nonhuman primates. J Bone Joint Surg 1995; 77A: 734-750.
27. 27. Cordewener F, Bos R, Rozema F, Houtman W. Poly(L-Lactide) implants for repair of human orbital floor defects: clinical and magnetic resonance imaging evaluation of long-term results. J Oral Maxillofac Surg 1996; 54: 9-13.
28. 28. Craig Gray J, Elves MW. Donor cells' contribution to osteogenesis in experimental cancellous bone grafts. Clin Orthop 1982; 163: 261-271.
29. 29. Dahlin C, Linde A, Gottlow J, Nyman S. Healing of bone defects by guided tissue regeneration. Plast Reconstr Surg 1988; 81: 672-676.
30. 30. Dahlin C, Alberius P, Linde A. Osteopromotion for cranioplasty. An experimental study in rats using a membrane technique. J Neurosurg 1991; 74: 487-191.
31. 31. Dahlin C, Andersson L, Linde A. Bone augmentation at fenestrated implants by an osteopromotive membrane technique. A controlled clinic study. Clin Oral Implant Res 1991; 2: 159-165.
32. 32. Dahlin C, Lekholm U, Linde A. Membrane induced bone augmentation at titanium implants. A report of 10 fixtures followed from 1 to 3 years after loading. Int J Periodontics Restorative Dent 1991; 11: 273-281.
33. 33. Dahlin C, Linde A, Röckert H. Stimulation of early bone formation by the combination of an osteopromotive membrane technique and hyperbaric oxygen. Scand J Plast Reconstr Surg Hand Surg 1993; 27: 103-108.
34. 34. Deleu J, Trueta J. Vascularization of bone grafts in the anterior chamber of the eye. J Bone Joint Surg 1965; 47: 319-329.
35. 35. Donovan MG, Dickerson NC, Hellstein JW, Hanson LJ. Autologous calvarial and iliac onlay bone grafts in miniature swine. J Oral Maxillofac Surg 1993; 51: 898-903.
36. 36. Ermis I, Poole M. The effects of soft tissue coverage on bone graft resorption in the craniofacial region. Br J Plast Surg 1992; 45: 26-29.
37. 37. Fasano D, Gasparini G, Menoni V, Bertoni F, Bacchini P. The fate of onlay membranous bone grafts in different facial recipient sites. Eur J Plast Surg 1989; 12: 160-166.
38. 38. Finkelman RD, Eason AL, Rakijian DE, Tutundzhyan Y, Hardesty RA. Elevated IGF-II and TGF-β concentrations in human calvarial bone: potential mechanism for increased graft survival and resistance to osteoporosis. Plast Reconstr Surg 1994; 93: 732-738.
39. 39. Fisher J, Wood MB. Experimental comparison of bone revascularization by musculocutaneous and cutaneous flaps. Plast Reconstr Surg 1987; 79: 81-90.
40. 40. Gendler E. Perforated demineralized bone matrix: A new form of osteoinductive biomaterial. J Biomed Mater Res 1986; 20: 687-697.
41. 41. Gerhart TN, Kirker-Head CA, Kriz MJ, et al. Healing segmental femural defects in sheep using recombinant human bone morphogenetic protein. Clin Orthop 1993; 293: 317-326.
42. 42. Goldstein J, Mase C, Newman MH. Fixed membranous bone graft survival after recipient bed alteration. Plast Reconstr Surg 1993; 91: 589-596.
43. 43. Goldstein JA, Mase CA, Newman MH. The influence of bony architecture on fixed membranous bone graft survival. Ann Plast Surg 1995; 34: 162-167.
44. 44. Gordh M, Alberius P, Lindberg L, Johnell O. Bone graft incorporation after cortical perforations of the host bed. Otolaryngol Head Neck Surg 1997; 117: 664-670.
45. 45. Gordh M, Alberius P, Johnell O, Lindberg L, Linde A. Osteopromotive membranes enhance onlay integration and maintenance in the adult rat skull. Int J Oral Maxillofac Surg 1998; 27: 67-73.
46. 46. Gordh M, Alberius P, Johnell O, Lindberg L, Linde A. Effects of rhBMP-2 and osteopromotive membranes on experimental bone grafting. Plast Reconstr Surg 1999; 103. In press.
47. 47. Gosain AK, McCarty JG, Staffenberg D, Glat PM, Simmons DJ. The histomorphologic changes in vascularizcd bone transfers and their interrelationship with the recipient sites: A 1-year study. Plast Reconstr Surg 1996; 97: 1001-1013.
48. 48. Gosain AK, Song L, Capel CC, Corrao MA, Lim T-H. Biomechanical and histologic alteration of facial recipient bone after reconstruction with autogenous bone grafts and alloplastic implants: a 1-year study. Plast Reconstr Surg 1998; 101: 1561-1571.
49. 49. Gottlow J, Nyman S, Karring T. Maintenance of new attachment gained through guided tissue regeneration. J Clin Periodontol 1992; 19: 315-317.
50. 50. Ham AW. Some histophysiological problems peculiar to calcified tissues. J Bone Joint Surg 1952; 34A: 701-728.
51. 51. Hardesty RA, Marsh JL. Craniofacial onlay bone grafting: a prospective evaluation of graft morphology, orientation, and embryonic origin. Plast Reconstr Surg 1990; 85: 5-14.
52. 52. Hardwick R, Hayes BK, Flynn C. Devices for dentoalveolar regeneration: an up-to-date literature review. J Periodontol 1995; 66: 495-505.
53. 53. Hedner E, Linde A, Nilsson A. Systematically and locally administered growth hormone stimulates bone healing in combination with osteopromotive membranes: an experimental study in rats. J Bone Miner Res 1996; 11: 1952-1960.
54. 54. Hollinger J. Factors for osseous repair and delivery: part I. J Craniofac Surg 1993; 4: 102-108.
55. 55. Hollinger J. Factors for osseous repair and delivery: part II. J Craniofac Surg 1993; 4: 135-141.
56. 56. Hollinger JO, Leong K. Poly(α-hydroxy acids): Carriers for bone morphogenetic proteins. Biomaterials 1996; 17: 187-194.
57. 57. Hogan BLM. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 1996; 10: 1580-1594.
58. 58. Iizuka T, Mikkonen P, Paukku P, Lindqvist C. Reconstruction of orbital floor with polydioxanone plate. Int J Oral Maxillofac Surg 1991; 20: 83-87.
59. 59. Isgaard J, Nilsson A, Lindahl A, Jansson JO, Isaksson OGP. Effects of local administration of GH and IGF-I on longitudinal bone growth in rats. Am J Physiol 1986; 250: E367-E372.
60. 60. Ishimaru J-I, Kurita K, Handa Y, Goss AN. Effect of marrow perforation on the sheep temporomandibular joint. Int J Oral Maxillofac Surg 1992; 21: 239-242.
61. 61. Kenley R, Marden L, Turek T, Jin L, Ron E, Hollinger JO. Osseous regeneration in the rat calvarium using novel delivery systems for recombinant human bone morphogenetic protein-2 (rhBMP-2). J Biomed Mater Res 1994; 28: 1139-1147.
62. 62. Knize D. The influence of periosteum and calcitonin on onlay bone graft survival. Plast Reconstr Surg 1974; 3: 190-199.
63. 63. Kobayashi K, Agrawal K, Jackson IT, Vega JB. The effect of insulin-like growth factor 1 on craniofacial bone healing. Plast Reconstr Surg 1996; 97: 1129-1135.
64. 64. Komaki M, Katagiri T, Suda T. Bone morphogenetic protein-2 does not alter the differentiation pathway of committed progenitors of osteoblasts and chondrablasts. Cell Tissue Res 1996; 284: 9-17.
65. 65. Körlof B, Nylén B, Ritz KA. Bone grafting of skull detects: a report of 55 cases. Plast Reconstr Surg 1973; 52: 378-383.
66. 66. Kusiak JF, Zins JE, Whitaker LA. The early revascularization of membranous bone. Plast Reconstr Surg 1985; 76: 510-514.
67. 67. Lance EM. Some observations on bone graft technology. Clin Orthop 1985; 200: 114-124.
68. 68. LaTrenta GA, McCarthy JG, Breitbart AS, Sissons HA. The role of rigid fixation in bone-graft augmentation of the craniofacial skeleton. Plast Reconstr Surg 1989; 84: 578-588.
69. 69. Levander G. A study ot bone regeneration. Surg Gynecol Obstet 1938; 67: 705-714.
70. 70. Lin KY, Bartlett SP, Yaremchuk MJ, Fallon M, Grossman RF, Whitaker LA. The effect of rigid fixation on the survival of onlay bone grafts: an experimental study. Plast Reconstr Surg 1990; 86: 449-456.
71. 71. Linde A, Alberius P, Dahlin C, Bjurstam K, Sundin Y. Osteopromotion: a soft tissue exclusion principle using a membrane for bone healing and bone neogenesis. J Periodontol 1993; 64: 1116-1128.
72. 72. Linde A, Hedner E. Recombinant bone morphogenetic protein-2 enhances bone healing, guided by osteopromotive e-PTFE membranes: an experimental study in rats. Calcif Tissue Int 1995; 56: 549-553.
73. 73. Lindholm TS, Urist MR. A quantitative analysis of new bone formation by induction in compositive grafts of bone marrow and bone matrix. Clin Orthop 1980; 150: 288-303.
74. 74. Lindholm TC, Gao TJ, Lindholm TS. The role of autogeneic bone marrow in the repair of a skull trephine defect tilled with hydroxyapatite granules in the rabbit. Int J Oral Maxillofac Surg 1994; 23: 306-311.
75. 75. Lozano AJ, Cestero HJ, Salyer KE. The early vascularization of onlay bone grafts. Plast Reconstr Surg 1976; 58: 302-305.
76. 76. Mowlem R. Bone grafting. Br J Plast Surg 1963; 16: 293-304.
77. 77. Nash TJ, Howlett CR, Martin C, Steele J, Johnson KA, Hicklin DJ. Effect of platelet-derived growth factor on tibial osteotomies in rabbits. Bone 1994; 15: 203-208.
78. 78. Nielsen HM, Andreassen TT, Ledet T, Oxlund H. Local injection of TGF-β increases the strength of tibial fractures in the rat. Acta Orthop Scand 1994; 65: 37-41.
79. 79. Nyman S, Linde J, Karring T. Reattachment - New Attachment. In: Linde J, ed. Textbook of Clinical Periodontology. Copenhagen: Munksgaard, 1988: 409-429.
80. 80. Oklund SA, Prolo DJ, Gutierrez RV, et al. Quantitative comparisons of healing in cranial fresh autografts, frozen autografts and processed autografts, and allografts in canine skull defects. Clin Orthop 1986; 205: 269-291.
81. 81. Ozaki W, Buchman SR. Volume maintenance of onlay bone grafts in the craniofacial skeleton: micro-architecture versus embryologic origin. Plast Reconstr Surg 1998; 102: 291-299.
82. 82. Özkaymak E, Schnegelsberg PNJ, Jin DF, et al. Osteogenic protein-2; a new member of the transforming growth factor-β super-family expressed early in embryogenesis. J Biol Chem 1992; 267: 25220-25227.
83. 83. Peer LA. The fate of autogenous human bone grafts. Br J Plast Surg 1950-1951; 3: 233-243.
84. 84. Phillips JH, Rahn BA. Fixation effects on membranous and endochondral onlay bone-graft resorption. Plast Reconstr Surg 1988; 82: 872-877.
85. 85. Phillips JH, Rahn BA. Fixation effects on membranous and endochondral onlay bone graft revascularization and bone deposition. Plast Reconstr Surg 1990; 85: 891-897.
86. 86. Piette P, Alberius P, Samman N, Linde A. Experience with e-PTFE membrane application to bone grafting of cleft maxilla. Int J Oral Maxillofac Surg 1995; 24: 327-332.
87. 87. Pinholt EM, Solheim E, Talsnes O, Larsen TB, Bang G, Kirkeby OJ. Revascularization of calvarial, mandibular, tibial, and iliac bone grafts in rats. Ann Plast Surg 1994; 33: 193-197.
88. 88. Prolo DJ, Rodrigo JJ. Contemporary bone graft physiology and surgery. Clin Orthop 1985; 200: 322-342.
89. 89. Puranen J. Reorganization of fresh and preserved bone transplants. Acta Orthop Scand 1966; suppl 92.
90. 90. Reddi AH. Cell biology and biochemistry of endochondral bone development. Coll Relat Res 1981; 1: 209-226.
91. 91. Ripamonti U, Duneas N. Tissue morphogenesis and regeneration by bone morphogenetic proteins. Plast Reconstr Surg 1998; 101: 227-239.
92. 92. Ripamonti U, van der Heever B, Sampath TK, Tucker MM, Rueger DC, Reddi AH. Complete regeneration of bone in the baboon by recombinant human osteogenic protein-1 (hOP-I, bone morphogenetic protein-7). Growth Factors 1996; 13: 273-289.
93. 93. Rønningen H, Solheim LF, Langeland N. Bone formation enhanced by induction. Bone growth in titanium implants in rats. Acta Orthop Scand 1985; 56: 67-71.
94. 94. Rosen V, Wozney JM, Wang EA, et al. Purification and molecular cloning of a novel group of BMPs and localization of BMP mRNA in developing bone. Connect Tissue Res 1989; 20: 313-319.
95. 95. Rudkin GH, Miller TA. Growth factors in surgery. Plast Reconstr Surg 1996; 97: 469-476.
96. 96. Salyer KE, Gendler E, Menedez J, Simon TR, Kelly KM, Barclach J. Demineralized perforated bone implants in craniofacial surgery. J Craniomaxillofac Surg 1992; 3: 55-62.
97. 97. Sampath TK, Muthukumaran N, Reddi AH. Isolation of osteogenin, an extracellular matrix-associated, bone-inductive protein, by heparin affinity chromatography. Proc Natl Acad Sci U S A 1987; 84: 7109-7113.
98. 98. Sandberg E, Dahlin C, Linde A. Bone regeneration by the osteopromotion technique using bioabsorbable membranes: an experimental study in rats. J Oral Maxillofac Surg 1993; 51: 1106-1114.
99. 99. Scantlebury TV. 1982-1992: a decade of technology development for guided tissue regeneration. J Periodontol 1993; 64: 1129-1137.
100. 100. Sigholm G, Gendler E, McKellop H, Marchall J, Moore T, Sarmiento A. Graft perforations favor osteoinduction. Studies of rabbit cortical grafts sterilized with ethylene oxide. Acta Orthop Scand 1992; 63: 177-182.
101. 101. Simmons DJ, Ellsasser JC, Cummins H, Lesker P. The bone inductive potential of a composite bone allograft-marrow autograft in rabbits. Clin Orthop 1973; 97: 237-247.
102. 102. Simmons HA, Raisz LG. Effects of acidic and basic fibroblast growth factor and heparin on resorption of cultured fetal rat long bone. J Bone Miner Res 1991; 6: 1301-1305.
103. 103. Simon P, Babin SR, Delloye C, Schmitt D. Les multiperformations des allogreffes osseuses cryoconservées. Ètude histologique et microradiographique comparative d'allogreffes perforées et non perforées chez le mouton. Int Orthop 1993; 17: 98-103.
104. 104. Smith JD, Abramson M. Membranous vs endochondral bone autografts. Arch Otolaryngol 1974; 99: 203-205.
105. 105. Stalnecker MC, Whitaker LA, Brighton CT. Electrical stimulation of onlay bone grafts. Plast Reconstr Surg 1988; 82: 580-586.
106. 106. Sullivan WG, Szwajkun PR. Revascularization of cranial versus iliac crest bone grafts in the rat. Plast Reconstr Surg 1991; 87: 1105-1109.
107. 107. Tarsoly E, Ostrowski K, Moskalewski S, Lojek T, Kurnatowski W, Krompecher ST. Incorporation of lyophilized and radiosterilized perforated and unperforated bone grafts in dogs. Acta Chir Acad Sci Hung 1969; 10: 55-63.
108. 108. Thaller SR, Dart A, Tesluk H. The effects of insulin-like growth factor-1 on critical size calvarial defects in Sprague-Dawley rats. Ann Plast Surg 1993; 31: 429-433.
109. 109. Thompson N, Casson JA. Experimental onlay bone grafts to the jaws. A preliminary study in dogs. Plast Reconstr Surg 1970; 46: 341-349.
110. 110. Toriumi DM, Kotler HS, Lusenberg DP, Holtrop MF, Wang EA. Mandibular reconstruction with a recombinant bone-inducing factor: functional, histologic and biomechanical evaluation. Arch Otolaryngol Head Neck Surg 1991; 117: 1101.
111. 111. Trueta J. The role of the vessels in osteogenesis. J Bone Joint Surg 1963; 45B: 402-418.
112. 112. Urist MR. Bone formation by autoinduction. Science 1965; 150: 893-899.
113. 113. Urist MR, Strates BS. Bone morphogenetic protein. J Dent Res 1971; 50: 1392-1406.
114. 114. Wang EA, Rosen V, D'Alessandro JS, et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci U S A 1990; 87: 2220-2224.
115. 115. Wang JS, Aspenberg P. Basic fibroblast growth factor and bone induction in rats. Acta Orthop Scand 1993; 64: 557-561.
116. 116. Wang JS, Aspenberg P. Basic fibroblast growth factor increases allograft incorporation. Bone chamber study in rats. Acta Orthop Scand 1994; 65: 27-31.
117. 117. Vikjaer D, Blom S, Hjørting-Hansen E, Pinholt EM. Effect of platelet-derived growth factor-BB on bone formation in calvarial defects: an experimental study in rabbits. Eur J Oral Sci 1997; 105: 59-66.
118. 118. Viljanen VV, Lindholm TC, Gao TS, Lindholm TS. Low dosage of native allogencic bone morphogeneic protein in repair of sheep calvarial defects. Int J Oral Maxillofac Surg 1997; 26: 389-393.
119. 119. Wilkes GH, Kernahan DA, Christenson M. The long-term survival of onlay bone grafts. A comparative study in mature and immature animals. Ann Plast Surg 1985; 15: 374-378.
120. 120. Wozney JM. The bone morphogenetic protein family and osteogenesis. Mol Reprod Dev 1992; 32: 160-167.
121. 121. Wozney JM. Molecular biology of bone morphogenetic proteins. In: Urist MR, O'Conner BT, Burwell RG, eds. Bone grafts, Derivatives & Substitutes. 1st ed. London: Butterworth-Heinemann, 1994: 397-411.
122. 122. Wozney JM. The bone morphogenetic protein family: multifactorial cellular regulators in the embryo and adult. Eur J Oral Sci 1998; 106 (suppl 1): 160-166.
123. 123. Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: molecular clones and activities. Science 1988; 242: 1528-1534.
124. 124. Zegzula HD, Buck DC, Brekke J, Wozney JM, Hollinger JO. Bone formation with use of rhBMP-2 (Recombinant human bone morphogenetic protein-2). J Bone Joint Surg 1997; 79A: 1178-1190.
125. 125. Zellin G. Growth factors and bone regeneration - implications of barrier membranes. Swed Dent J 1998; suppl 129: 1-65.
126. 126. Zellin G, Gritli-Linde A, Linde A. Healing of mandibular defects with different biodegradable and non-biodegradable membranes: an experimental study in rats. Biomaterials 1995; 16: 601-609.
127. 127. Zellin G, Linde A. Treatment of segmental defects in long bones using osteopromotive membranes and recombinant human bone morphogenetic protein-2. Scand J Plast Reconstr Surg Hand Surg 1997; 30: 99-106.
128. 128. Zellin G, Linde A. Importance of delivery systems for growth-stimulatory factors in combination with osteopromotive membranes. An experimental study using rhBMP-2 in rat mandibular defects. J Biomed Mater Res 1997; 35: 181-190.
129. 129. Zellin G, Alberius P, Linde A. Autoclaved bone for craniofacial reconstruction: effects of supplementation with bone marrow or recombinant human fibroblast growth factor-2. Plast Reconstr Surg 1998; 102: 792-800.
130. 130. Zellin G, Beck S, Hardwick R, Linde A. Opposite effects of recombinant human transforming growth factor-β1 on bone regeneration in vivo: effects of exclusion of periosteal cells by microporous membrane. Bone 1998; 22: 613-620.
131. 131. Zins JE, Whitaker LA. Membranous versus endochondral bone. Implications for craniofacial reconstruction. Plast Reconstr Surg 1983; 72: 778-784.
132. 132. Zins JE, Kusiak JF, Whitaker LA, Enlow DH. The influence of the recipient site on bone grafts to the face. Plast Reconstr Surg 1984; 73: 371-379.
133. 133. Yamada K, Tabata Y, Yamamoto K, et al. Potential efficiacy of basic fibroblast growth factor incorporated in biodegradable hydrogels for skull bone regeneration. J Neurosurg 1997; 86: 871-875.
134. 134. Yanagisawa A, Nakamura T, Arakaki M, Yano H, Yamashita S, Fujii T. Migration of hydroxyapatite onlays into the mandible and nasal bone and local bone turnover in growing rabbits. Plast Reconstr Surg 1997; 99: 1972-1982.